Last update:

Immunology news

Diseases, Conditions, Syndromes

Allogeneic HCT feasible in older patients with myelodysplastic syndrome

Allogeneic hematopoietic cell transplantation (allo-HCT) is feasible in older patients with myelodysplastic syndrome (MDS), according to a study published online June 26 in the European Journal of Haematology.

Health

Immunity to seasonal flu protects against severe illness from bird flu in ferrets, research reveals

The fatality rate for H5N1 highly pathogenic avian influenza in humans has historically been high, with more than half of people dying. Why, then, is the current H5N1 bird flu outbreak—which has caused massive die-offs ...

Immunology

Study uncovers how the immune system fends off gut parasites

New research from the University of Pittsburgh reveals how the immune system defends against intestinal parasitic worms, or helminths, one of the most common infections worldwide in communities with limited access to clean ...

Oncology & Cancer

Cancer-fighting radioisotope being optimized for therapeutic use

A promising breakthrough in cancer treatment is taking shape at the University of Missouri Research Reactor (MURR), where scientists are developing a powerful radioisotope that could one day precisely target and destroy cancer ...

Immunology

Surprising finding could pave way for universal cancer vaccine

An experimental mRNA vaccine has boosted the tumor-fighting effects of immunotherapy in a mouse-model study, bringing researchers one step closer to their goal of developing a universal vaccine to "wake up" the immune system ...

Oncology & Cancer

Novel complex induces immunogenic cancer cell death

Two junior research groups at Ruhr University Bochum, Germany, have developed a drug complex that kills cancer cells in such a clever manner that they raise a red flag as they die. They signal to the immune system that something ...

Oncology & Cancer

Biomarker may predict immunotherapy response in liver cancer

It may soon be possible to determine which patients with a type of liver cancer called hepatocellular carcinoma would benefit from immunotherapy, according to a preclinical study by Weill Cornell Medicine investigators.

Oncology & Cancer

Scientists explore new mechanisms to combat glioblastoma

Glioblastoma is the most common and aggressive type of primary brain tumor, with an average survival rate of 15 months, according to the Centers for Disease Control and Prevention. While glioblastoma can be diagnosed at any ...

Immunology

Unique immune response in lupus paves the way for new treatments

Immune cells called monocytes produce a key inflammatory protein called interleukin-1 beta (IL-1β) through an unconventional pathway in patients with systemic lupus erythematosus, commonly referred to as lupus, according ...

Genetics

Uncovering a way for pro-B cells to change trajectory

Development of B cells, white blood cells that make antibodies, follows a progression of stages: common lymphoid progenitors, pre-pro-B cells, pro-B cells, pre-B cells, immature B cells, and then more mature and specialized ...

Oncology & Cancer

Immune signatures may predict adverse events from immunotherapy

Distinct immune "signatures" in patients who develop adverse events while receiving immunotherapy for cancer may help oncologists identify patients at risk and treat them early to prevent serious side effects, suggests a ...

Neuroscience

Study helps understand pain associated with viral infection

A study published in the journal Brain, Behavior, and Immunity reports the findings of a study by researchers based in Brazil, the United States and South Korea who set out to understand how viral infections cause pain and ...

Diseases, Conditions, Syndromes

Inside RSV: Researchers pinpoint markers of more severe cases

Respiratory syncytial virus (RSV) remains the top cause of hospitalization among young children, leading to respiratory issues like bronchiolitis and pneumonia. However, the reasons why some children experience only mild ...